Interleukin-1 and naproxen down-regulate the expression of IL-1 receptors in cultured human rheumatoid synovial cells (HRSC)

Agents Actions Suppl. 1993;39:213-7. doi: 10.1007/978-3-0348-7442-7_24.

Abstract

Using affinity binding of [125I]-IL-1 alpha and Scatchard analysis, we demonstrate here that exposure of cultured synovial cells (HRSC) to NPX (10(-4) M) for 96 h decreased the binding of IL-1 by 20 to 35%. This effect results from a down-regulation of the IL-1 receptors without change in the apparent binding affinity (kD: 770 pM). Pretreatment of cultures with IL-1 alpha (500 pg/ml) reduced the total binding of [125I]-IL-1 alpha on HRSC by 65%, indicating that IL-1 decreases the expression of its own receptors.

MeSH terms

  • Arthritis, Rheumatoid / pathology*
  • Down-Regulation / drug effects*
  • Humans
  • Interleukin-1 / metabolism
  • Interleukin-1 / pharmacology*
  • Iodine Radioisotopes
  • Kinetics
  • Naproxen / pharmacology*
  • Receptors, Interleukin-1 / drug effects*
  • Receptors, Interleukin-1 / metabolism
  • Recombinant Proteins / pharmacology
  • Synovial Membrane / pathology*

Substances

  • Interleukin-1
  • Iodine Radioisotopes
  • Receptors, Interleukin-1
  • Recombinant Proteins
  • Naproxen